Rescue clinical trials, which can have a delayed estimated start date or delayed estimated end date, often require outside sourcing, such as to contract research organisations (CROs), to successfully complete. GlobalData’s Pharma Intelligence Centre has compiled data on rescue trials, showing a trend in the completion rate.
Since the Covid-19 pandemic began, sponsors have turned to the use of virtual trials components to successfully initiate and complete trials. When looking at the completion rate of rescue trials since 2010, those with virtual components had a higher completion rate by 3.2%. Rescue trials that used both virtual components and a CRO did even better, with an 84.5% completion rate compared with trials that had neither virtual components nor CROs (78.8%), as seen in Figure 1. These data points indicate that the usage of not only virtual components, but also CROs, increases the chances of successfully completing a rescue clinical trial.